Research programme: integrin modulating recombinant protein therapeutics - Applied Integrin SciencesAlternative Names: ADM-01; Vicrostatin
Latest Information Update: 02 Oct 2013
At a glance
- Originator Applied Integrin Sciences
- Class Disintegrins; Recombinant proteins
- Mechanism of Action Angiogenesis inhibitors; Apoptosis stimulants; Integrin modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Ovarian cancer; Solid tumours
Most Recent Events
- 25 Sep 2013 Preclinical trials in Solid tumours in USA (Parenteral)
- 25 Sep 2013 Preclinical trials in Ovarian cancer in USA (Parenteral)